Treatment Strategies in Hepatocellular Carcinoma (HCC): Optimizing Outcomes and Resource Allocation

home / peer-exchange / treatment-strategies-in-hepatocellular-carcinoma-hcc-optimizing-outcomes-and-resource-allocation

Clinical pathways considerations and key treatment strategies for hepatocellular carcinoma (HCC) are discussed by a panel of medical experts.

Episodes

October 16th 2023EP. 1: Evaluating Clinical Pathway Implementation in HCC Treatment

A panel of medical experts open a discussion surrounding key treatment strategies in management of hepatocellular carcinoma (HCC).

October 16th 2023EP. 2: The Impact of Clinical Pathways on Healthcare Resource Allocation in HCC Management

Ghassan Abou-Alfa, MD, MBA, and Mohamed Salem, MD, provide insights regarding potential clinical pathway-driven challenges associated with HCC management.

October 23rd 2023EP. 3: Identifying and Navigating Challenges Associated With Clinical Pathways in the Treatment of HCC

Ryan Haumschild, PharmD, MS, MBA, drives an expert discussion focused on challenges associated with clinical pathway utilization in treating patients with HCC.

October 23rd 2023EP. 4: Clinical Pathways and Streamlined Decision-Making in HCC Management

Benefits of clinical pathway implementation in HCC management are examined.

October 30th 2023EP. 5: Patient Engagement and Clinical Pathways in HCC

Medical experts discuss patient considerations when utilizing clinical pathways in HCC treatment.

October 30th 2023EP. 6: HIMALAYA Study and IMbrave150 Trial

An overview of the HIMALAYA study and IMbrave150 trial are provided.

November 6th 2023EP. 7: Time-to-Response Correlation to HCC Treatment Effectiveness and Patient Prognosis

Expert panelists discuss key factors contributing to “time to response” in HCC treatment, and its impact on patient prognosis.

November 6th 2023EP. 8: Navigating Adverse Events Associated With HCC Treatment

Dr Abou-Alfa discusses strategies to mitigate the impact of adverse events in patients receiving treatment for HCC.

Segment 9 - "Managing Adverse Events to Sustain Continuity in HCC Treatment"

November 14th 2023EP. 9: Managing Adverse Events to Sustain Continuity in HCC Treatment

Treatment continuity and adherence in HCC can be encouraged through patient education and engagement.

Segment 10 - "Assessing Cost-Effective Treatment Options in HCC"

November 14th 2023EP. 10: Assessing Cost-Effective Treatment Options in HCC

Cost-effectiveness considerations are highlighted by Dr Abou-Alfa.

November 20th 2023EP. 11: The Decision-Making Process Behind Elective Gastroscopy (EGD) in the Treatment of HCC.

The decision to perform an EGD is evaluated between academic and community health care perspectives.

November 20th 2023EP. 12: Maximizing Health Care Resource Utilization in HCC

Richard Kim, MD, offers perspective regarding optimal use of health care resources in the management of HCC.

November 27th 2023EP. 13: Key Toxicity Profiles in the Treatment of HCC

Dr Haumschild leads a discussion surrounding toxicity profiles specifically related to HCC.

November 27th 2023EP. 14: Navigating HCC Treatment-Related Toxicities

Toxicity management in HCC treatment is discussed by medical experts.

December 4th 2023EP. 15: Toxicity Profiles and Their Impact on the Quality of Life for Patients with HCC

Dr Salem opens a conversation highlighting the impact of toxicity profiles on a patient’s quality of life, and Dr. Abou-Alfa examines the consequences of treatment-related toxicities in HCC on the utilization of healthcare resources.

December 4th 2023EP. 16: Resource Allocation Strategies in HCC Treatment

Medical experts offer strategies for assessing and allocating health care resources in HCC management.

December 4th 2023EP. 17: Key Considerations in the Management of HCC

The panelists provide their closing thoughts from a discussion highlighting key considerations in treatment and management of HCC.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions